Eurobio Scientific Team

Press releases

Current year

2025

Eurobio Scientific increases its footprint in Italy

March 12, 2025

Calendrier de publications financières 2025

Janvier 15, 2025 (FR)

Prior years

Eurobio Scientific : succès de l’OPA à l’issue de sa première période, réouverture de l’offre du 4 au 17 décembre

November 29, 2024 (FR)

Opening of the public purchase offer until November 27

October 24, 2024 (FR)

Eurobio Scientific: lifting of the last regulatory suspensive condition to the takeover bid project initiated by EB Development

October 16, 2024 (FR)

Results for the first half of 2024

September 24, 2024

Eurobio Scientific completes acquisition of Endopredict® genomic test from Myriad Genetics

August 2, 2024

Suspension of the liquidity contract

August 1, 2024 (FR)

First half 2024, a solid start of the financial year in an uncertain environment - PROPOSED TENDER OFFER

July 31, 2024

Agreement to acquire the ENDOPREDICT gene expression test for breast cancer

May 7, 2024

Publication of the 2023 financial annual report

April 26, 2024 (FR)

2023 annual results, growth in Core Business and strategic deployment

April 9, 2024

2023 Annuel revenue at 130,1 MEUR

January 30, 2024

Capital reduction through cancellation of treasury shares-2024

January 9, 2024

Catherine Courboillet to join the Board as an Independant Member

November 7, 2023

Availability of the 2023 half-yearly financial report

October 30, 2023 (FR)

GenDx reduces organ matching time to 3 hours

October 17, 2023

H1 2023 Results: Solid performance of Core Business and acceleration of strategic deployment

October 11, 2023

Acceleration of strategic deployment in the first half of 2023

July 24, 2023

Capital reduction through cancellation of treasury shares

July 11, 2023

All resolutions approved at the 2023 Annual General Meeting - The Board of Directors appoints a new governance

June 16, 2023

Acquisition of D.I.D. in Italy

June 13, 2023

First IVDR CE marking of PCR tests

May 23, 2023

Publication of the 2022 annual financial report

April 28, 2023 (FR)

2022 annual results : very strong performance and strengthening of the Core Business

April 5, 2023

Wietse Mulder, CEO of GenDx, holds a 2% stake in Eurobio Scientific

February 14, 2023

Eurobio Scientific formalises the appointment of Anne-Sophie Herelle as Group CFO

February 8, 2023

2022 annual turnover of €152.5M

January 23, 2023

H2 2022 report on the liquidity contract

January 5, 2023 (FR)

Exclusive commercial agreement for the distribution of a diagnostic test that predicts response to a treatment for pancreatic cancer

November 22, 2022

Half-year financial report available

October 27, 2022 (FR)

H1 2022 Results: continued growth of non-COVID activity

October 11, 2022

Eurobio Scientific finalizes the acquisition of GenDx, international HLA diagnostics specialist

October 3, 2022

Eurobio Scientific signs an agreement to acquire GenDx, international HLA diagnostics specialist

August 17, 2022

First half turnover of €83.6 million maintained at a high level

July 25, 2022

Half-year report on liquidity contract

July 11, 2022 (FR)

Launch of 2 new proprietary tests : new variants of SARS-CoV-2, and Monkeypox

June 20, 2022

Eurobio Scientific's annual shareholders' meeting

June 14, 2022 (FR)

Eurobio Scientific expands into Benelux by acquiring the diagnostic company Biomedical Diagnostics NV

June 13, 2022

Closing of the Strategic Partnership with NEXTSTAGE AM

May 18, 2022

Availability of the 2021 annual financial report

April 28, 2022 (FR)

Eurobio Scientific partners with Dr. Nino Guy Cassuto for the development of a new PCR test for male fertility

April 26, 2022

CE mark for Eurobio Scientific’s new proprietary test for the detection of Omicron BA.x, BA.2 and Delta variants of SARS-CoV-2

April 14, 2022

Maintaining high level results in 2021

April 6, 2022

New priority test for the detection of Omicron BA.x, BA.2 and Delta of SARS-CoV-2

February 7, 2022

Strategic partnership with NextStage AM

February 7, 2022

2021 TURNOVER : Exceptional level of €184.1million

January 24, 2022

Eurobio Scientific launches the exclusive distribution of the first saliva self-test for HIV testing in France

January 11, 2022

Eurobio Scientific confirms its eligibility to the pea-pme system

January 10, 2022 (FR)

You may also like

Press releases
Eurobio Scientific Group acquire the assets of the Life Science unit of Voden Medical Instruments S.p.A.
Read More
Oncology
Eurobio Scientific Group has successfully completed the acquisition of Quimark SRL
Read More
Oncology
Eurobio Scientific Expands Oncology Portfolio with Biovica Partnership
Read More
EurobioPlex
EBX 071 Achieves CE-IVDR Certification
Read More
EurobioPlex
First IVDR CE marking of PCR tests
Read More
News Group
Successful start into 2025
Read More
Events Group
Meet the Eurobio Scientific Group team at Medlab Middle East 2025!
Read More
News Group
Meet the visionaries behind our success!
Read More
Events Group
MEDICA – Leading International Trade Fair
Read More
Two Days of Exchange and Sharing for the Global Marketing Team
News Group
Two Days of Exchange and Sharing for the Global Marketing Team
Read More
The Secret Behind Our Success: A Peek Inside Our Cologne Labs
Events Group
The Secret Behind Our Success: A Peek Inside Our Cologne Labs
Read More
Eurobio Scientific FR
🚀 Forum Labo 2025 is off to a flying start! 🚀
Read More
Eurobio Scientific FR
🚀 The SFTA Congress is underway!
Read More
Eurobio Scientific FR
🔬 Virion/Serion Training: An Enriching Experience! 🔬
Read More
Eurobio Oncology
Our last day at St.Gallen 2025!
Read More
EurobioDID
New Partnership: Cube Dx & Eurobio DID get off to a flying start in Italy
Read More
EurobioGenDx
Elevated and Inspired!
Read More
EurobioDID
DID is now Eurobio!
Read More
Eurobio Oncology
Advancing Care for Premenopausal Breast Cancer Patients
Read More
Eurobio Scientific FR
Une installation au service de la recherche et de la santé !
Read More
EurobioGenDx
Move Your Body, Stretch Your Mind
Read More
Eurobio Scientific FR
Movember : Tous en Bleu et avec la Moustache ! 🎗 Chez Eurobio Scientific
Read More
Eurobio Scientific FR
A look back at the 1st Disability Week at Eurobio Scientific
Read More
Eurobio Scientific FR
IONIS STM school jobdating
Read More
DE
PINK DAY – Oncology
Read More
DE
Focused on Progress
Read More
EurobioGenDx
Introducing NGS-Pronto® – High-resolution Nanopore HLA typing
Read More
Eurobio Scientific UK
34th Annual British Society for Histocompatibility and Immunogenetics (BSHI) conference
Read More
Eurobio Scientific FR
Journée mondiale contre le cancer du sein
Read More
EurobioBMD
First Helios Installation in Benelux by BMD
Read More
EurobioTECO
New Partnership: TECOmedical and DIESSE
Read More

Search

de_DE
de_DE fr_FR en_GB it_IT es_ES
Nach oben scrollen